DK2247589T3 - 7-azaindolderivater som selektive 11-beta-hydroxysteroid-dehydrogenase type 1-inhibitorer - Google Patents
7-azaindolderivater som selektive 11-beta-hydroxysteroid-dehydrogenase type 1-inhibitorerInfo
- Publication number
- DK2247589T3 DK2247589T3 DK08802728.9T DK08802728T DK2247589T3 DK 2247589 T3 DK2247589 T3 DK 2247589T3 DK 08802728 T DK08802728 T DK 08802728T DK 2247589 T3 DK2247589 T3 DK 2247589T3
- Authority
- DK
- Denmark
- Prior art keywords
- aza
- inhibitors
- beta
- selective
- hydroxysteroid dehydrogenase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07291325 | 2007-11-05 | ||
| PCT/EP2008/008309 WO2009059666A1 (en) | 2007-11-05 | 2008-10-01 | 7-azaindole derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2247589T3 true DK2247589T3 (da) | 2013-01-21 |
Family
ID=40445347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08802728.9T DK2247589T3 (da) | 2007-11-05 | 2008-10-01 | 7-azaindolderivater som selektive 11-beta-hydroxysteroid-dehydrogenase type 1-inhibitorer |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8470849B2 (da) |
| EP (1) | EP2247589B1 (da) |
| JP (1) | JP5529743B2 (da) |
| KR (1) | KR101624596B1 (da) |
| CN (1) | CN101848910B (da) |
| AU (1) | AU2008324525B2 (da) |
| BR (1) | BRPI0819219B1 (da) |
| CA (1) | CA2704803C (da) |
| CO (1) | CO6270308A2 (da) |
| CY (1) | CY1113645T1 (da) |
| DK (1) | DK2247589T3 (da) |
| EA (1) | EA019707B1 (da) |
| EC (1) | ECSP10010231A (da) |
| ES (1) | ES2400105T3 (da) |
| HR (1) | HRP20130097T1 (da) |
| IL (1) | IL205508A (da) |
| MX (1) | MX2010004815A (da) |
| PL (1) | PL2247589T3 (da) |
| PT (1) | PT2247589E (da) |
| SI (1) | SI2247589T1 (da) |
| UA (1) | UA102379C2 (da) |
| WO (1) | WO2009059666A1 (da) |
| ZA (1) | ZA201004023B (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| DK2563780T3 (da) | 2010-04-29 | 2015-07-27 | Univ Edinburgh | 3,3-disubstituerede-(8-aza-bicyclo[3.2.1]oct-8-yl)-[5-(1h-pyrazol-4-yl)-thiophen-3-yl]-methanoner som inhibitorer af 11(beta)-hsd1 |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP3235813A1 (en) | 2016-04-19 | 2017-10-25 | Cidqo 2012, S.L. | Aza-tetra-cyclo derivatives |
| CN106279154A (zh) * | 2016-08-02 | 2017-01-04 | 叶芳 | 一种7‑氮杂吲哚‑3‑甲醛的制备方法 |
| EP4172158A4 (en) * | 2020-06-30 | 2024-01-10 | Univ California | COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH |
| CN112390815B (zh) * | 2020-11-03 | 2022-07-26 | 浙江医药股份有限公司新昌制药厂 | 一种Lewis酸脱N-苄基制备d-生物素的制备方法 |
| CN112409353A (zh) * | 2020-11-27 | 2021-02-26 | 苏州艾缇克药物化学有限公司 | 一种7-氮杂吲哚衍生物的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL156517A0 (en) * | 2000-12-22 | 2004-01-04 | Wyeth Corp | Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| DE10252666A1 (de) * | 2002-11-11 | 2004-08-05 | Grünenthal GmbH | N-Piperidyl-cyclohexan-Derivate |
| DE10337184A1 (de) * | 2003-08-13 | 2005-03-10 | Gruenenthal Gmbh | Substituierte 3-Pyrrolidin-Indol-Derivate |
| NZ546012A (en) * | 2003-10-14 | 2009-12-24 | Pfizer Prod Inc | Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
| US20080015214A1 (en) * | 2005-10-24 | 2008-01-17 | Bignan Gilles C | 3-piperidin-4-yl-indole orl-1 receptor modulators |
| US7638062B2 (en) | 2006-07-10 | 2009-12-29 | Cameron International Corporation | Ultra compact cyclonic flotation system |
-
2008
- 2008-10-01 UA UAA201006828A patent/UA102379C2/ru unknown
- 2008-10-01 EP EP08802728A patent/EP2247589B1/en active Active
- 2008-10-01 MX MX2010004815A patent/MX2010004815A/es active IP Right Grant
- 2008-10-01 AU AU2008324525A patent/AU2008324525B2/en not_active Ceased
- 2008-10-01 KR KR1020107012222A patent/KR101624596B1/ko active IP Right Grant
- 2008-10-01 PL PL08802728T patent/PL2247589T3/pl unknown
- 2008-10-01 WO PCT/EP2008/008309 patent/WO2009059666A1/en active Application Filing
- 2008-10-01 JP JP2010531433A patent/JP5529743B2/ja active Active
- 2008-10-01 EA EA201000751A patent/EA019707B1/ru not_active IP Right Cessation
- 2008-10-01 PT PT88027289T patent/PT2247589E/pt unknown
- 2008-10-01 DK DK08802728.9T patent/DK2247589T3/da active
- 2008-10-01 SI SI200830889T patent/SI2247589T1/sl unknown
- 2008-10-01 CN CN2008801146395A patent/CN101848910B/zh active Active
- 2008-10-01 CA CA2704803A patent/CA2704803C/en active Active
- 2008-10-01 BR BRPI0819219-7A patent/BRPI0819219B1/pt active IP Right Grant
- 2008-10-01 ES ES08802728T patent/ES2400105T3/es active Active
- 2008-10-01 US US12/741,254 patent/US8470849B2/en active Active
-
2010
- 2010-05-03 IL IL205508A patent/IL205508A/en active IP Right Grant
- 2010-05-05 CO CO10053458A patent/CO6270308A2/es not_active Application Discontinuation
- 2010-06-03 EC EC2010010231A patent/ECSP10010231A/es unknown
- 2010-06-04 ZA ZA2010/04023A patent/ZA201004023B/en unknown
-
2013
- 2013-02-05 HR HRP20130097AT patent/HRP20130097T1/hr unknown
- 2013-02-08 CY CY20131100113T patent/CY1113645T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2247589T1 (sl) | 2013-03-29 |
| ZA201004023B (en) | 2011-03-30 |
| HRP20130097T1 (hr) | 2013-02-28 |
| EA201000751A1 (ru) | 2010-12-30 |
| CN101848910A (zh) | 2010-09-29 |
| PL2247589T3 (pl) | 2013-03-29 |
| JP2011502135A (ja) | 2011-01-20 |
| WO2009059666A1 (en) | 2009-05-14 |
| EP2247589A1 (en) | 2010-11-10 |
| CY1113645T1 (el) | 2016-06-22 |
| IL205508A0 (en) | 2010-12-30 |
| CA2704803C (en) | 2017-04-11 |
| AU2008324525A1 (en) | 2009-05-14 |
| PT2247589E (pt) | 2013-02-20 |
| AU2008324525B2 (en) | 2014-09-18 |
| BRPI0819219A2 (pt) | 2020-08-04 |
| ECSP10010231A (es) | 2010-07-30 |
| EP2247589B1 (en) | 2012-11-21 |
| US20100267761A1 (en) | 2010-10-21 |
| US8470849B2 (en) | 2013-06-25 |
| EA019707B1 (ru) | 2014-05-30 |
| CN101848910B (zh) | 2013-12-04 |
| KR101624596B1 (ko) | 2016-05-26 |
| CA2704803A1 (en) | 2009-05-14 |
| IL205508A (en) | 2013-06-27 |
| JP5529743B2 (ja) | 2014-06-25 |
| KR20100094500A (ko) | 2010-08-26 |
| UA102379C2 (ru) | 2013-07-10 |
| ES2400105T3 (es) | 2013-04-05 |
| CO6270308A2 (es) | 2011-04-20 |
| MX2010004815A (es) | 2010-05-27 |
| BRPI0819219B1 (pt) | 2021-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2247589T3 (da) | 7-azaindolderivater som selektive 11-beta-hydroxysteroid-dehydrogenase type 1-inhibitorer | |
| DK2094263T3 (da) | 2-adamantyl-butyramidderivater som selektive 11 beta-hsd1-inhibitorer | |
| LTC1907382I2 (lt) | Nitrokatechnolio dariniai, kaip COMT inhibitoriai | |
| DK2125748T3 (da) | Acylaminopyrazol som FGFR inhibitorer | |
| DK1959951T3 (da) | Heteroaryl-substituerede piperidinderivater som L-CPT1-inhibitorer | |
| DK2078001T3 (da) | Diazepan-acetamidderivater som selektive 11-HSD1-inhibitorer | |
| DK2086939T3 (da) | Pyridiacarboxamid som II-beta-HSDI-inhibitorer | |
| DE602007012870D1 (de) | Verzehrbare bohrlochwerkzeuge | |
| NL2000537A1 (nl) | Aminederivaten. | |
| DK2021335T3 (da) | Heterocykliske forbindelser som C-FMS-kinasehæmmere | |
| DK2102205T3 (da) | Pyridopyrazinderivater anvendelige som herbicidale forbindelser | |
| DK2160389T3 (da) | Thioxoquinazolinonderivater som glutaminylcyclaseinhibitorer | |
| DK2220070T3 (da) | 2-benzylpyridazinonderivater som Met-kinaseinhibitorer | |
| DK1981892T3 (da) | Thienopyridinderivater som mek-inhibitorer | |
| DK2160380T3 (da) | Cyano-guanidin derivater som glutaminyl cyclase inhibitorer | |
| ATE487691T1 (de) | Acetylenderivate | |
| DK2142514T3 (da) | Thioureaderivater som glutaminylcyclase-inhibitorer | |
| DK1937671T3 (da) | Benzimidazolthiophenforbindelser som PLK-inhibitorer | |
| DK2007396T3 (da) | Enfumafungin-derivat som antimykotika | |
| DK2049480T3 (da) | 2-arylindolderivater som mPGES-1-hæmmere | |
| DE112006004211A5 (de) | Bohrfutter | |
| BRPI0813354A2 (pt) | Derivado de morfolina | |
| DK2220060T3 (da) | Tetrahydrobenzothiazolderivater | |
| DE112007003237A5 (de) | Nachspannendes Bohrfutter | |
| DE112008002921A5 (de) | Bohrfutter |